MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair

BioMed Research International

Volumn 2017, Issue , 2017, Pages

  Shao, Lianbo ^a   Zhang, Yu ^a   Lan, Beibei ^a   Wang, Juanjuan ^a   Zhang, Zhiwei ^a   Zhang, Lulu ^a   Xiao, Pengli ^a   Meng, Qingyou ^a   Geng, Yong Jian ^b   Yu, Xi Yong ^c   Li, Yangxin ^a  

^a SOOCHOW UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 103 3P; MICRORNA 130; MICRORNA 130 5P; MICRORNA 133A 3P; MICRORNA 133C; MICRORNA 1378A 5P; MICRORNA 15; MICRORNA 15A 3P; MICRORNA 16 5P; MICRORNA 17 5P; MICRORNA 1B; MICRORNA 21 3P; MICRORNA 21 5P; MICRORNA 23B 3P; MICRORNA 24; MICRORNA 24 3P; MICRORNA 24A 3P; MICRORNA 29; MICRORNA 29A 5P; MICRORNA 29B 3P; MICRORNA 30E 5P; MICRORNA 31A 5P; MICRORNA 331 5P; MICRORNA 34C 5P; MICRORNA 3587; MICRORNA 874 3P; MICRORNA 92A 3P; MICRORNA 99A 3P; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CARDITIS; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; EXOSOME; FIBROBLAST; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE FIBROSIS; IN VITRO STUDY; INTERNALIZATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; RAT; RNA SEQUENCE; UPREGULATION; ANGIOGENESIS; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PARACRINE SIGNALING; PATHOLOGY; REGENERATION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; EXOSOMES; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; RATS; REGENERATION;

EID: 85012215389     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/4150705     Document Type: Article

References (40)

1. R. Uemura, M. Xu, N. Ahmad, and M. Ashraf, "Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling, " Circulation Research, vol. 98, no. 11, pp. 1414-1421, 2006.
2. M. Takaku, S. Tomita, H. Kurobe et al., "Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells, " PLoS ONE, vol. 7, no. 8, Article ID e42964, 2012.
3. M. Rosenberg, M. Lutz, C. Kühl et al., "Coculture with hematopoietic stem cells protects cardiomyocytes against apoptosis via paracrine activation of AKT, " Journal of Translational Medicine, vol. 10, article 115, 2012.
4. J. M. Hare, J. H. Traverse, T. D. Henry et al., "A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after acute myocardial infarction, " Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277-2286, 2009.
5. J. M. Hare, J. E. Fishman, G. Gerstenblith et al., "Comparison of allogeneic vs autologous bonemarrow-derivedmesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial, " JAMA, vol. 308, no. 22, pp. 2369-2379, 2012.
6. S. K. Sanganalmath and R. Bolli, "Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions, " Circulation Research, vol. 113, no. 6, pp. 810-834, 2013.
7. S. Golpanian, D. L. DiFede, M. V. Pujol et al., "Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: a phase I/II, randomized, blinded and placebo controlled trial to evaluate the Safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty, " Oncotarget, vol. 7, no. 11, pp. 11899-11912, 2016.
8. R. A. Boon and S. Dimmeler, "MicroRNAs in myocardial infarction, " Nature Reviews Cardiology, vol. 12, no. 3, pp. 135-142, 2015.
9. Y. Li, Z. Shen, and X.-Y. Yu, "Transport of microRNAs via exosomes, " Nature Reviews Cardiology, vol. 12, no. 4, p. 198, 2015.
10. E. Cervio, L. Barile, T. Moccetti, and G. Vassalli, "Exosomes for intramyocardial intercellular communication, " Stem Cells International, vol. 2015, Article ID 482171, 10 pages, 2015.
11. S. R. Baglio, K. Rooijers, D. Koppers-Lalic et al., "Human bone marrow-and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species, " Stem Cell Research andTherapy, vol. 6, no. 1, article 127, 2015.
12. C. Subra, D. Grand, K. Laulagnier et al., "Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins, " Journal of Lipid Research, vol. 51, no. 8, pp. 2105-2120, 2010.
13. C. Théry, M. Ostrowski, and E. Segura, "Membrane vesicles as conveyors of immune responses, " Nature Reviews Immunology, vol. 9, no. 8, pp. 581-593, 2009.
14. X. Teng, L. Chen, W. Chen, J. Yang, Z. Yang, and Z. Shen, "Mesenchymal stem cell-derived exosomes improve the microenvironment of infarctedmyocardium contributing to angiogenesis and anti-inflammation, " Cellular Physiology and Biochemistry, vol. 37, no. 6, pp. 2415-2424, 2015.
15. R. A. Boomsma and D. L. Geenen, "Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis, " PlOS one, vol. 7, no. 4, Article ID e35685, 2012.
16. R. C. Lai, F. Arslan, M. M. Lee et al., "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury, " Stem Cell Research, vol. 4, no. 3, pp. 214-222, 2010.
17. S. Bian, L. Zhang, L. Duan, X. Wang, Y. Min, and H. Yu, "Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model, " Journal of Molecular Medicine, vol. 92, no. 4, pp. 387-397, 2014.
18. X. Sun, B. Fang, X. Zhao, G. Zhang, and H. Ma, "Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential, " PLoS ONE, vol. 9, no. 3, Article ID e90667, 2014.
19. J.-A. Cho, Y.-S. Lee, S.-H. Kim, J.-K. Ko, and C.-W. Kim, "MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression inmurine models, " Cancer Letters, vol. 275, no. 2, pp. 256-265, 2009.
20. A. Brill, O. Dashevsky, J. Rivo, Y. Gozal, and D. Varon, "Plateletderived microparticles induce angiogenesis and stimulate postischemic revascularization, " Cardiovascular Research, vol. 67, no. 1, pp. 30-38, 2005.
21. S. Atay, C. Gercel-Taylor, M. Kesimer, and D. D. Taylor, "Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells, " Experimental Cell Research, vol. 317, no. 8, pp. 1192-1202, 2011.
22. K. E. Hatzistergos, H. Quevedo, B. N. Oskouei et al., "Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation, " Circulation Research, vol. 107, no. 7, pp. 913-922, 2010.
23. H. Kawada, J. Fujita, K. Kinjo et al., "Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes aftermyocardial infarction, " Blood, vol. 104, no. 12, pp. 3581-3587, 2004.
24. M. E. Padin-Iruega, Y. Misao, M. E. Davis et al., "Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction, " Circulation, vol. 120, no. 10, pp. 876-887, 2009.
25. Y. Iso, K. S. Rao, C. N. Poole et al., "Priming with ligands secreted by human stromal progenitor cells promotes grafts of cardiac stem/progenitor cells after myocardial infarction, " Stem Cells, vol. 32, no. 3, pp. 674-683, 2014.
26. L. Zentilin, U. Puligadda, V. Lionetti et al., "Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction, " FASEB Journal, vol. 24, no. 5, pp. 1467-1478, 2010.
27. M. T. Harting, F. Jimenez, S. Pati, J. Baumgartner, and C. S. Cox, "Immunophenotype characterization of rat mesenchymal stromal cells, " Cytotherapy, vol. 10, no. 3, pp. 243-253, 2008.
28. A. Biernacka, M. Dobaczewski, andN. G. Frangogiannis, "TGF-β signaling in fibrosis, " Growth Factors, vol. 29, no. 5, pp. 196-202, 2011.
29. Z. Zhang, J. Yang, W. Yan, Y. Li, Z. Shen, and T. Asahara, "Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhancesmyocardial repair, " Journal of the AmericanHeart Association, vol. 5, no. 1, Article IDe002856, 2016.
30. S. Sahoo, E. Klychko, T. Thorne et al., "Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity, " Circulation Research, vol. 109, no. 7, pp. 724-728, 2011.
31. S.-G. Ong, W. H. Lee, M. Huang et al., "Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNAtransfer, " Circulation, vol. 130, no. 11, S1, pp. S60-S69, 2014.
32. B. Wang, R. Komers, R. Carew et al., "Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis, " Journal of the American Society of Nephrology, vol. 23, no. 2, pp. 252-265, 2012.
33. L. Maegdefessel, J. M. Spin, U. Raaz et al., "miR-24 limits aortic vascular inflammation andmurine abdominal aneurysm development, "Nature Communications, vol. 5, article 5214, 2014.
34. L. Qian, L. W. Van Laake, Y. Huang, S. Liu, M. F. Wendland, and D. Srivastava, "miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes, " Journal of Experimental Medicine, vol. 208, no. 3, pp. 549-560, 2011.
35. R. A. Boon, K. Iekushi, S. Lechner et al., "MicroRNA-34a regulates cardiac ageing and function, " Nature, vol. 495, no. 7439, pp. 107-110, 2013.
36. B. C. Bernardo, X.-M. Gao, C. E. Winbanks et al., "Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 43, pp. 17615-17620, 2012.
37. Y. Li, C.-M. Yang, Y. Xi et al., "MicroRNA-1/133 targeted dysfunction of potassium channels KCNE1 and KCNQ1 in human cardiac progenitor cells with simulated hyperglycemia, " International Journal of Cardiology, vol. 167, no. 3, pp. 1076-1078, 2013.
38. J. Ganesan, D. Ramanujam, Y. Sassi et al., "MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors, " Circulation, vol. 127, no. 21, pp. 2097-2106, 2013.
39. C. Bang, S. Batkai, S. Dangwal et al., "Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy, " Journal of Clinical Investigation, vol. 124, no. 5, pp. 2136-2146, 2014.
40. T. G. Hullinger, R. L. Montgomery, A. G. Seto et al., "Inhibition of miR-15 protects against cardiac ischemic injury, " Circulation Research, vol. 110, no. 1, pp. 71-81, 2012.